Speaker Profile
JD, President, CaliberMRI
Biography
Callie Weiant leads CaliberMRI's efforts to advance quantitative MRI (qMRI) for precision medicine and AI applications. The company is focused on collaborations and strategic partnerships with researchers, clinicians, and industry to advance standards and data quality. After practicing law at a national law firm, Callie has spent her career working with startups.
Talk
Quantiative MRI is the future, but it needs standards
Quantiative Magnetic Resonance Imaging (qMRI) is the future. qMRI, where outputs are measured in absolute units, enables robust AI algorithms and allows data comparion across sites and over time. However, implementation and adoption of qMRI requires investment in QA, metrology, and standards. This talk outlines needs and solutions to transform qMRI and precision medicine.
Clinical & Research Tools Showcase:
CaliberMRI
CaliberMRI, Inc. is on a mission to improve the standard of care by advancing the field of quantitative MR imaging (qMRI). We offer a fully-integrated platform for clinical trials, AI/ML/DL validation and testing, and routine multi-site QA/QC.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 Clinical & Research Tools Showcase will provide a 15-30 minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.
